Amedeo's Top 20

Amedeo Smart

Independent Medical Education

08 May 2023

Multidisciplinary Journal Club

  1. Ray JG, Schull MJ, Vermeulen MJ, Park AL, et al.
    Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ann Intern Med 2020.

  1. Nedelec T, Couvy-Duchesne B, Darves-Bornoz A, Couronne R, et al.
    A comparison between early presentation of dementia with Lewy Bodies, Alzheimer's disease and Parkinson's disease: evidence from routine primary care and UK Biobank data.
    Ann Neurol 2023.

  2. Saul H, Deeney B, Imison C, Tesfaye S, et al.
    Combination therapy for painful diabetic neuropathy is safe and effective.
    BMJ 2023;381:p866.

  3. Andre F, Hee Park Y, Kim SB, Takano T, et al.
    Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
    Lancet 2023.

  4. .
    EASL-ILCA Clinical Practice Guidelines on Intrahepatic Cholangiocarcinoma.
    J Hepatol 2023.

  1. Guo Z, Zhao Q, Jia Z, Huang C, et al.
    A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease.
    J Hepatol 2023.

  2. Krauss DJ, Karrison T, Martinez AA, Morton G, et al.
    Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial.
    J Clin Oncol 2023.

  3. Atia O, Magen Rimon R, Ledderman N, Greenfeld S, et al.
    Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
    Inflamm Bowel Dis 2023.

  4. Barden MM, Omuro AM.
    Top advances of the year: Neuro-oncology.
    Cancer 2023;129:1467-1472.

  5. Al Ohaly R, Benoit ME, Schuster MG.
    Infectious Diseases: What You May Have Missed in 2022.
    Ann Intern Med 2023.

  1. Altersberger VL, Sibolt G, Enz LS, Hametner C, et al.
    Intravenous Thrombolysis 4.5-9 Hours After Stroke Onset - a Cohort Study from the TRISP Collaboration.
    Ann Neurol 2023.

  2. El-Kassas M, Emadeldeen M, Hassany M, Esmat G, et al.
    A randomized controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C.
    J Hepatol 2023.

  3. Burke RM, Nliwasa M, Dodd PJ, Feasey HR, et al.
    Impact of community-wide tuberculosis active case finding and HIV testing on tuberculosis trends in Malawi.
    Clin Infect Dis 2023.

  4. Murphy RP, Reddin C, Rosengren A, Judge C, et al.
    Depressive Symptoms and Risk of Acute Stroke: INTERSTROKE Case-Control Study.
    Neurology 2023.

  5. Jing J, Ge W, Hong S, Fernandes MB, et al.
    Development of Expert-Level Classification of Seizures and Rhythmic and Periodic Patterns During EEG Interpretation.
    Neurology 2023;100:e1750-e1762.

  1. Cohen-Mekelburg S, Van T, Berinstein JA, Yu X, et al.
    Characteristics of Facilities with Early and Rapid Ustekinumab Adoption for Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol 2023.

  2. Chahal JK, Sriranganathan D, Poo S, Lo SW, et al.
    Network meta-analysis: efficacy and safety of treatments for fistulising Crohn's disease.
    Eur J Gastroenterol Hepatol 2023.

  3. Koutsouraki E, Theodoros K, Eleni G, Marianna K, et al.
    Autonomic nervous system disorders in multiple sclerosis.
    J Neurol 2023.

  4. Foschi M, Pavolucci L, Rondelli F, Barone V, et al.
    Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort.
    Cerebrovasc Dis 2023;52:218-225.

  5. Barrio M, Raeburn CD, McIntyre R Jr, Albuja-Cruz M, et al.
    Computer-Assisted Levothyroxine Dose Selection for the Treatment of Postoperative Hypothyroidism.
    Thyroid 2023.


more..

Privacy Policy